Ionpath Overview
- Founded
- 2014

- Status
- Private
- Employees
- 44

- Latest Deal Type
- Series B
- Latest Deal Amount
- $18M

- Investors
- 12
Ionpath General Information
Description
Developer of an ion beam imaging technology designed to provide analysis of tissue biopsies. The company's imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen or FFPE, enabling health care providers to provide diagnosis of cancer for improving human health.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- 960 O'Brien Drive
- Menlo Park, CA 94025
- United States
+1 (833) 000-0000
Ionpath Timeline
Ionpath Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series B) | 24-Sep-2020 | $18M | 0000 | 0000 | Completed | Generating Revenue |
3. Debt - PPP | 14-Apr-2020 | 0000 | Completed | Generating Revenue | ||
2. Early Stage VC (Series A) | 01-Jul-2019 | $30.4M | $33M | 000.00 | Completed | Generating Revenue |
1. Early Stage VC (Series A1) | $2.6M | $2.6M | 000.00 | Completed | Startup |
Ionpath Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.00 | |
Series A-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
Series A | 5,355,296 | $0.000100 | $3.58 | $3.58 | 1x | $3.58 | 11.16% |
Ionpath Executive Team (7)
Ionpath Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Aaron Sandoski | Norwich Ventures | Board Observer | 000 0000 |
Frank Lee Ph.D | Self | Board Member | 000 0000 |
Jenny Rooke Ph.D | Self | Board Observer | 000 0000 |
Michael Angelo Ph.D | Ionpath | Co-Founder & Board Member | 000 0000 |
Michael Dybbs Ph.D | Self | Board Member | 000 0000 |
Ionpath Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIonpath Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bruker | Corporation | Minority | 000 0000 | 000000 0 | |
DragonScale Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
ND Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Norwich Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Paladin Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 |